{"brief_title": "Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent", "brief_summary": "To compare two lipid emulsions in the long-term parenteral alimentation of patients with AIDS in relation to: Clinical effectiveness. Effect on immunologic function. Effect on HIV load as measured by p24 antigen levels. Effect on relative HIV infectivity.", "condition": "HIV Infections", "intervention_type": "Drug", "intervention_name": "Fat Emulsion 20%", "criteria": "Inclusion Criteria Concurrent Medication: Allowed: - Zidovudine (AZT). - All drugs used for the standard treatment of opportunistic infections. - Other drugs used for the treatment of other AIDS conditions if they have been started more than 3 months prior to study entry. Patients must have: - Diagnosis of AIDS. - Weight loss of > 10 percent premorbid body weight. - Presenting diagnosis of either opportunistic infection or Kaposi's sarcoma. - Require home total parenteral nutrition (TPN) for a period of approximately 3 months. - Life expectancy = or > 90 days. Prior Medication: Allowed: - Zidovudine (AZT). Exclusion Criteria Co-existing Condition: Patients with the following conditions or symptoms are excluded: - Life expectancy < 90 days. - Biliary stasis. - History of drug abuse. Patients with the following are excluded: - Life expectancy < 90 days. - Biliary stasis. - History of drug abuse. Prior Medication: Excluded within 3 months of study entry: - Immunomodulators. - Experimental antiviral DT. History of drug abuse.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "60 Years", "healthy_volunteers": "No", "id": "NCT00002029.xml"}